Choosing and using Drosophila models to characterize modifiers of Huntington's disease

Biochemical Society Transactions

Volumn 40, Issue 4, 2012, Pages 739-745

  Green, Edward W ^a   Giorgini, Flaviano ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Drosophila; Genetic modifier; Genetic screening; Huntington's disease; Neurodegeneration

Indexed keywords

ACTIN; CASPASE 6; HUNTINGTIN; RHODOPSIN; SIRTUIN; TRANSCRIPTION FACTOR GAL4; TUBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CELL DEATH; CONFERENCE PAPER; DROSOPHILA; FERTILITY; GENE INSERTION; GENE OVEREXPRESSION; HEAT SENSITIVITY; HIGH THROUGHPUT SCREENING; HUMAN; HUNTINGTON CHOREA; LOCOMOTION; LONGEVITY; MUTAGENESIS; NERVE DEGENERATION; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RNA INTERFERENCE;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; HUNTINGTON DISEASE; MICROTUBULE-ASSOCIATED PROTEINS; NEURODEGENERATIVE DISEASES;

EID: 84864393010     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20120072     Document Type: Conference Paper

References (56)

1. The Huntington's disease collaborative research group. (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983
2. Wexler, N.S., Lorimer, J., Porter, J., Gomez, F., Moskowitz, C., Shackell, E., Marder, K., Penchaszadeh, G., Roberts, S.A., Gayán, J. et al. (2004) Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl. Acad. Sci. U.S.A. 101, 3498-3503 (Pubitemid 38338224)
3. Djousse, L., Knowlton, B., Hayden, M., Almqvist, E.W., Brinkman, R., Ross, C., Margolis, R., Rosenblatt, A., Durr, A., Dode, C. et al. (2003) Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease. Am. J. Med. Genet., Part A 119, 279-282 (Pubitemid 37063854)
4. Gusella, J.F. and MacDonald, M.E. (1998) Huntingtin: a single bait hooks many species. Curr. Opin. Neurobiol. 8, 425-430 (Pubitemid 28288581)
5. Becanovic, K., Pouladi, M.A., Lim, R.S., Kuhn, A., Pavlidis, P., Luthi-Carter, R., Hayden, M.R. and Leavitt, B.R. (2010) Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysis. Hum. Mol. Genet. 19, 1438-1452
6. Gusella, J.F. and Macdonald, M.E. (2009) Huntington's disease: the case for genetic modifiers. Genome Med. 1, 80
7. Andresen, J.M., Gayán, J., Cherny, S.S., Brocklebank, D., Alkorta-Aranburu, G., Addis, E.A., Cardon, L.R., Housman, D.E. and Wexler, N.S. (2007) Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds. J. Med. Genet. 44, 44-50 (Pubitemid 46142838)
8. Li, J.L., Hayden, M.R., Almqvist, E.W., Brinkman, R.R., Durr, A., Dode, C., Morrison, P.J., Suchowersky, O., Ross, C.A., Margolis, R.L. et al. (2003) A genome scan for modifiers of age at onset in Huntington disease: the HD MAPS study. Am. J. Hum. Genet. 73, 682-687 (Pubitemid 37076283)
9. Li, J.L., Hayden, M.R., Warby, S.C., Durr, A., Morrison, P.J., Nance, M., Ross, C.A., Margolis, R.L., Rosenblatt, A., Squitieri, F. et al. (2006) Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med. Genet. 7, 71
10. Gayán, J., Brocklebank, D., Andresen, J.M., Alkorta-Aranburu, G., Cader, M.Z., Roberts, S.A., Cherny, S.S., Wexler, N.S., Cardon, L.R. and Housman, D.E. (2008) Genomewide linkage scan reveals novel loci modifying age of onset of Huntington's disease in the Venezuelan HD kindreds. Genet. Epidemiol. 32, 445-453
11. Willingham, S., Outeiro, T.F., DeVit, M.J., Lindquist, S.L. and Muchowski, P.J. (2003) Yeast genes that enhance the toxicity of a mutant Huntingtin fragment or α-synuclein. Science 302, 1769-1772 (Pubitemid 37505741)
12. Doumanis, J., Wada, K., Kino, Y., Moore, A.W. and Nukina, N. (2009) RNAi screening in Drosophila cells identifies new modifiers of mutant Huntingtin aggregation. PLoS ONE 4, e7275
13. Zhang, S., Binari, R., Zhou, R. and Perrimon, N. (2010) A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. Genetics 184, 1165-1179
14. Aiken, C.T., Tobin, A.J. and Schweitzer, E.S. (2004) A cell-based screen for drugs to treat Huntington's disease. Neurobiol. Dis. 16, 546-555 (Pubitemid 38942987)
15. Li, Z., Karlovich, C.A., Fish, M.P., Scott, M.P. and Myers, R.M. (1999) A putative Drosophila homolog of the Huntington's disease gene. Hum. Mol. Genet 8, 1807-1815 (Pubitemid 29423893)
16. Greenspan, R.J. (1997) A kinder, gentler genetic analysis of behavior: dissection gives way to modulation. Curr. Opin. Neurobiol. 7, 805-811
17. Ambegaokar, S.S., Roy, B. and Jackson, G.R. (2010) Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease and amyotrophic lateral sclerosis. Neurobiol. Dis. 40, 29-39
18. Kazemi-Esfarjani, P. and Benzer, S. (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837-1840 (Pubitemid 30143971)
19. Wu, J., Shih, H.P., Vigont, V., Hrdlicka, L., Diggins, L., Singh, C., Mahoney, M., Chesworth, R., Shapiro, G., Zimina, O. et al. (2011) Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment. Chem. Biol. 18, 777-793
20. Apostol, B.L., Kazantsev, A., Raffioni, S., Illes, K., Pallos, J., Bodai, L., Slepko, N., Bear, J.E., Gertler, F.B., Hersch, S. et al. (2003) A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila. Proc. Natl. Acad. Sci. U.S.A. 100, 5950-5955 (Pubitemid 36576913)
21. Campesan, S., Green, E.W., Breda, C., Sathyasaikumar, K.V., Muchowski, P.J., Schwarcz, R., Kyriacou, C.P. and Giorgini, F. (2011) The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. Curr. Biol. 21, 961-966
22. Jackson, G.R., Salecker, I., Dong, X., Yao, X., Arnheim, N., Faber, P.W., MacDonald, M.E. and Zipursky, S.L. (1998) Polyglutamine-expanded human huntingtin transgenes induce degeneration of Drosophila photoreceptor neurons. Neuron 21, 633-642 (Pubitemid 28475514)
23. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739-743 (Pubitemid 33009952)
24. Reference deleted
25. Marsh, J.L., Walker, H., Theisen, H., Zhu, Y.Z., Fielder, T., Purcell, J. and Thompson, L.M. (2000) Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila. Hum. Mol. Genet. 9, 13-25 (Pubitemid 30145284)
26. Agrawal, N., Pallos, J., Slepko, N., Apostol, B.L., Bodai, L., Chang, L.W., Chiang, A.S., Thompson, L.M. and Marsh, J.L. (2005) Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc. Natl. Acad. Sci. U.S.A. 102, 3777-3781 (Pubitemid 40354688)
27. Le Bourg, E. and Lints, F.A. (1992) Hypergravity and aging in Drosophila melanogaster. 5. Patterns of movement. Gerontology 38, 65-70
28. Kahsai, L. and Zars, T. (2011) Learning and memory in Drosophila: behavior, genetics, and neural systems. Int. Rev. Neurobiol. 99, 139-167
29. Rubin, G.M. and Spradling, A.C. (1982) Genetic transformation of Drosophila with transposable element vectors. Science 218, 348-353 (Pubitemid 12037603)
30. Weiss, K.R., Kimura, Y., Lee, W.C. and Littleton, J.T. (2012) Huntingtin aggregation kinetics and their pathological role in a Drosophila Huntington's disease model. Genetics 190, 581-600
31. Lee, W.C., Yoshihara, M. and Littleton, J.T. (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 3224-3229 (Pubitemid 38327762)
32. Brand, A.H. and Perrimon, N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401-415 (Pubitemid 23214028)
33. Duffy, J.B. (2002) GAL4 system in Drosophila: a fly geneticist's Swiss army knife. Genesis 34, 1-15
34. Hassan, B.A., Bermingham, N.A., He, Y., Sun, Y., Jan, Y.N., Zoghbi, H.Y. and Bellen, H.J. (2000) Atonal regulates neurite arborization but does not act as a proneural gene in the Drosophila brain. Neuron 25, 549-561
35. Schulte, J., Sepp, K.J., Wu, C., Hong, P. and Littleton, J.T. (2011) High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model. PLoS ONE 6, e23841
36. Romero, E., Cha, G.H., Verstreken, P., Ly, C.V., Hughes, R.E., Bellen, H.J. and Botas, J. (2008) Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron 57, 27-40
37. Berger, C., Renner, S., Luer, K. and Technau, G.M. (2007) The commonly used marker ELAV is transiently expressed in neuroblasts and glial cells in the Drosophila embryonic CNS. Dev. Dyn. 236, 3562-3568 (Pubitemid 350276412)
38. Kazemi-Esfarjani, P. and Benzer, S. (2002) Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1. Hum. Mol. Genet 11, 2657-2672 (Pubitemid 35174695)
39. Sang, T.K., Li, C., Liu, W., Rodriguez, A., Abrams, J.M., Zipursky, S.L. and Jackson, G.R. (2005) Inactivation of Drosophila apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis. Hum. Mol. Genet. 14, 357-372 (Pubitemid 40227371)
40. Tamura, T., Sone, M., Yamashita, M., Wanker, E.E. and Okazawa, H. (2009) Glial cell lineage expression of mutant ataxin-1 and huntingtin induces developmental and late-onset neuronal pathologies in Drosophila models. PLoS ONE 4, e4262
41. Tonoki, A., Kuranaga, E., Ito, N., Nekooki-Machida, Y., Tanaka, M. and Miura, M. (2011) Aging causes distinct characteristics of polyglutamine amyloids in vivo. Genes Cells 16, 557-564
42. Groth, A.C., Fish, M., Nusse, R. and Calos, M.P. (2004) Construction of transgenic Drosophila by using the site-specific integrase from phage φC31. Genetics 166, 1775-1782 (Pubitemid 38621059)
43. Markstein, M., Pitsouli, C., Villalta, C., Celniker, S.E. and Perrimon, N. (2008) Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes. Nat. Genet. 40, 476-483 (Pubitemid 351450875)
44. Burnett, C., Valentini, S., Cabreiro, F., Goss, M., Somogyvari, M., Piper, M.D., Hoddinott, M., Sutphin, G.L., Leko, V., McElwee, J.J. et al. (2011) Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nat. Neurobiol. Dis. 477, 482-485
45. Pfeiffer, B.D., Ngo, T.T., Hibbard, K.L., Murphy, C., Jenett, A., Truman, J.W. and Rubin, G.M. (2010) Refinement of tools for targeted gene expression in Drosophila. Genetics 186, 735-755
46. Kramer, J.M. and Staveley, B.E. (2003) GAL4 causes developmental defects and apoptosis when expressed in the developing eye of Drosophila melanogaster. Genet. Mol. Res. 2, 43-47 (Pubitemid 38846548)
47. Liu, Y. and Lehmann, M. (2008) A genomic response to the yeast transcription factor GAL4 in Drosophila. Fly 2, 92-98
48. Ford, D., Hoe, N., Landis, G.N., Tozer, K., Luu, A., Bhole, D., Badrinath, A. and Tower, J. (2007) Alteration of Drosophila life span using conditional, tissue-specific expression of transgenes triggered by doxycyline or RU486/Mifepristone. Exp. Gerontol. 42, 483-497 (Pubitemid 46756091)
49. Marsh, J.L., Pallos, J. and Thompson, L.M. (2003) Fly models of Huntington's disease. Hum. Mol. Genet. 12, R187-R193 (Pubitemid 37259331)
50. Allikian, M.J., Deckert-Cruz, D., Rose, M.R., Landis, G.N. and Tower, J. (2002) Doxycycline-induced expression of sense and inverted-repeat constructs modulates phosphogluconate mutase (pgm) gene expression in adult Drosophila melanogaster. Genome Biol. 3, research0021
51. Stebbins, M.J., Urlinger, S., Byrne, G., Bello, B., Hillen, W. and Yin, J.C. (2001) Tetracycline-inducible systems for Drosophila. Proc. Natl. Acad. Sci. U.S.A. 98, 10775-10780 (Pubitemid 32878696)
52. Hay, B.A., Maile, R. and Rubin, G.M. (1997) P element insertion-dependent gene activation in the Drosophila eye. Proc. Natl. Acad. Sci. U.S.A. 94, 5195-5200 (Pubitemid 27214760)
53. Rorth, P. (1998) Gal4 in the Drosophila female germline. Mech. Dev. 78, 113-118
54. Steffan, J.S., Bodai, L., Pallos, J., Poelman, M., McCampbell, A., Apostol, B.L., Kazantsev, A., Schmidt, E., Zhu, Y.Z., Greenwald, M. et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413, 739-743 (Pubitemid 33009952)
55. Kaltenbach, L.S., Romero, E., Becklin, R.R., Chettier, R., Bell, R., Phansalkar, A., Strand, A., Torcassi, C., Savage, J., Hurlburt, A. et al. (2007) Huntingtin interacting proteins are genetic modifiers of neurodegeneration. PLoS Genet. 3, e82
56. Zhang, S., Feany, M.B., Saraswati, S., Littleton, J.T. and Perrimon, N. (2009) Inactivation of drosophila huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model. Dis. Model. Mech. 2, 247-266